...
首页> 外文期刊>Medicinal chemistry >Synthesis and Structure-Activity Relationship; Exploration of some Potent Anti-Cancer Phenyl Amidrazone Derivatives
【24h】

Synthesis and Structure-Activity Relationship; Exploration of some Potent Anti-Cancer Phenyl Amidrazone Derivatives

机译:合成与结构 - 活动关系; 探索一些有效的抗癌苯基氨基吡酮衍生物

获取原文
获取原文并翻译 | 示例

摘要

Background: Amidrazones have been reported to have significant anti-tumor propertiesagainst several cancer cell lines.Objectives: The current project aims to profile the structure-anticancer activity relationship ofphenyl-amidrazons.Methods: Fifteen phenyl-amidrazone-piperazine derivatives were prepared and tested against fourcancer cell lines (leukemia, prostate, breast and colon cancers).Results: Six compounds illustrated low micromolar anticancer IC50 values, while the remainingcompounds were either inactive or of moderate potencies. All compounds were virtually nontoxicagainst normal fibroblast cells.Conclusion: Docking into the oncogenic kinase bcr/abl illustrated the critical importance of (i) phalogensubstituent on the ligand's phenyl ring and (ii) the presence of positive ionizable moiety atthe ligand's piperazine fragment for anticancer activity.
机译:背景:据报道,氨基甲酮具有显着的抗肿瘤性能against几种癌细胞系。目前的项目旨在介绍苯基-Midrazons的结构 - 抗癌活性关系。方法:制备十五个苯基 - 氨基吡嗪 - 哌嗪衍生物并进行测试 四癌人细胞系(白血病,前列腺,乳腺癌和结肠癌)。结果:六种化合物所示的低微摩尔抗癌IC50值,而剩余的分数是无活性或中等的抗体。 所有化合物几乎是Nontoxicagainst正常成纤维细胞。结论:将致癌激酶BCR / ABL中的结合示出了(i)含量苯基环上的(i)含量的胆核系物的临界重要性,(ii)阳性可离子化部分在配体的哌嗪片段中抗癌活性的存在 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号